| A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer (NCT03632941) | Herbert Lyerly | 2019-03-01 |
| High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28 (NCT03329183) | Shanghai Changzheng Hospital | 2019-03-01 |
| Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum (NCT03785691) | Nordsjaellands Hospital | 2019-03-01 |
| Neoadjuvant Radiotherapy for HCC Involving Type I PVTT (NCT04025437) | Guangxi Medical University | 2019-03-01 |
| Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC (NCT03876587) | Zhejiang Cancer Hospital | 2019-03-01 |
| Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery (NCT03851172) | Assiut University | 2019-03-01 |
| Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis (NCT03866330) | Medical University of Warsaw | 2019-03-01 |
| Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction (NCT03423667) | Salvatore Campanella | 2019-03-01 |
| Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer (NCT03818282) | Huazhong University of Science and Technology | 2019-03-01 |
| Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma (NCT03682276) | Imperial College London | 2019-03-01 |
| The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients. (NCT06795698) | Hospital Civil de Guadalajara | 2019-03-01 |
| Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy (NCT03817736) | The University of Hong Kong | 2019-03-01 |
| Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia (NCT03348033) | Hospital de Clinicas de Porto Alegre | 2019-03-01 |
| A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris (NCT03780166) | Incyte Corporation | 2019-03-01 |
| Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis (NCT03702738) | The Aurum Institute NPC | 2019-03-01 |
| Latiglutenase as a Treatment for Celiac Disease (NCT03585478) | Immunogenics, LLC | 2019-03-01 |
| Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy (NCT03903185) | Ain Shams University | 2019-03-01 |
| Magnesium Sulphate Versus Fentanyl Sedation During Burr-hole Surgery (NCT03854812) | Kasr El Aini Hospital | 2019-03-01 |
| Effect of Intravenous Dynastat on Postoperative Sore Throat (NCT03915561) | Buddhist Tzu Chi General Hospital | 2019-03-01 |
| Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba (NCT03834935) | St Joseph University, Beirut, Lebanon | 2019-03-01 |
| Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis (NCT03927898) | Chinese Academy of Medical Sciences | 2019-03-01 |
| Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA) (NCT03779841) | AbbVie | 2019-03-01 |
| Trial of PCC Versus FFP in Patients Undergoing Heart Surgery (NCT03715348) | Queen Mary University of London | 2019-03-01 |
| Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients (NCT04536467) | Beni-Suef University | 2019-03-01 |
| Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients (NCT05621005) | Samar Atef Sebaweh Mohammed | 2019-03-01 |
| Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia (NCT03774537) | Children's Hospital of Chongqing Medical University | 2019-03-01 |
| Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer (NCT03929094) | Fudan University | 2019-03-01 |
| A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer (NCT03941873) | BeiGene | 2019-02-28 |
| Colorectal Metastasis Prevention International Trial 2 (NCT03919461) | Assaf-Harofeh Medical Center | 2019-02-28 |
| Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery (NCT03745794) | M.D. Anderson Cancer Center | 2019-02-28 |
| D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer (NCT03861156) | InventisBio Co., Ltd | 2019-02-28 |
| A Study of INCB050465 in Primary Sjögren's Syndrome (NCT03627065) | Incyte Corporation | 2019-02-28 |
| Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance (NCT03579654) | OncBioMune Pharmaceuticals | 2019-02-28 |
| Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy (NCT03839446) | Robert Redner, MD | 2019-02-28 |
| Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy (NCT03824587) | Ardelyx | 2019-02-28 |
| Study of ANAVEX2-73 in Patients With Rett Syndrome (NCT03758924) | Anavex Life Sciences Corp. | 2019-02-28 |
| 24 Month Open Label Study of the Tolerability and Efficacy of Inotersen in TTR Amyloid Cardiomyopathy Patients (NCT03702829) | Brigham and Women's Hospital | 2019-02-28 |
| MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN) (NCT03469284) | M.D. Anderson Cancer Center | 2019-02-28 |
| Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection (NCT04147208) | Sunshine Lake Pharma Co., Ltd. | 2019-02-28 |
| A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant (NCT03739502) | University of Rochester | 2019-02-28 |
| A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis (NCT03737812) | AbbVie | 2019-02-27 |
| A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC) (NCT04700449) | Connect Biopharm LLC | 2019-02-27 |
| A Study of CNSA-001 in Women With Diabetic Gastroparesis (NCT03712124) | PTC Therapeutics | 2019-02-27 |
| Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa (NCT03827798) | Novartis Pharmaceuticals | 2019-02-27 |
| BGJ398 for the Treatment of Tumor-Induced Osteomalacia (NCT03510455) | National Institute of Dental and Craniofacial Research (NIDCR) | 2019-02-27 |
| ET-01 in Subjects With Lateral Canthal Lines, LCL-209 (NCT03912805) | Eirion Therapeutics Inc. | 2019-02-27 |
| Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT03862157) | M.D. Anderson Cancer Center | 2019-02-27 |
| A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies (NCT03913741) | Genmab | 2019-02-27 |
| N-Acetylcysteine for Adolescent Alcohol Use Disorder (NCT03707951) | Medical University of South Carolina | 2019-02-27 |
| Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study (NCT03820063) | Borstkanker Onderzoek Groep | 2019-02-27 |
| CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients (NCT03769298) | University of Wisconsin, Madison | 2019-02-27 |
| Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer (NCT03786081) | Seagen, a wholly owned subsidiary of Pfizer | 2019-02-27 |
| The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC) (NCT03851939) | Sun Yat-sen University | 2019-02-26 |
| A Bridging Study of the SYN023 on Healthy Adult Subjects (NCT04495569) | Synermore Biologics (Suzhou) Co., Ltd. | 2019-02-26 |
| Eribulin in Brain Metastases From HER2-negative Breast Cancer (NCT03637868) | Institut Paoli-Calmettes | 2019-02-26 |
| Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ (NCT03935685) | University of California, Irvine | 2019-02-26 |
| A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2) (NCT03861793) | Mural Oncology, Inc | 2019-02-26 |
| Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer (NCT03880877) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2019-02-26 |
| Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") (NCT03400254) | Abramson Cancer Center at Penn Medicine | 2019-02-26 |
| A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease. (NCT03845387) | Kissei Pharmaceutical Co., Ltd. | 2019-02-26 |
| Metformin for Pulmonary Hypertension HFpEF (NCT03629340) | University of California, San Francisco | 2019-02-26 |
| A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia (NCT03885011) | Orasis Pharmaceuticals Ltd. | 2019-02-26 |
| The Effect of Intravenous Ketamine on Non Suicidal Self Injuries. (NCT04242914) | Tel-Aviv Sourasky Medical Center | 2019-02-25 |
| A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration (NCT03869684) | Senju Pharmaceutical Co., Ltd. | 2019-02-25 |
| GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases (NCT03765983) | Dana-Farber Cancer Institute | 2019-02-25 |
| Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a (NCT03697824) | GlaxoSmithKline | 2019-02-25 |
| A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) (NCT03599713) | Incyte Corporation | 2019-02-25 |
| Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer (NCT03839823) | Novartis Pharmaceuticals | 2019-02-25 |
| Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes (NCT03816761) | Novo Nordisk A/S | 2019-02-25 |
| Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors (NCT04001075) | TJ Biopharma Co., Ltd. | 2019-02-25 |
| Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD) (NCT03639623) | Zydus Therapeutics Inc. | 2019-02-25 |
| Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression (NCT03965858) | Celon Pharma SA | 2019-02-25 |
| Mepivacaine Versus Low-Dose Bupivacaine For Primary Total Hip and Knee Arthroplasty (NCT03838874) | Mayo Clinic | 2019-02-25 |
| A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes (NCT05353686) | Pila Pharma | 2019-02-25 |
| 48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO) (NCT03845075) | Saniona | 2019-02-25 |
| Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease (NCT03672630) | Kevin Winthrop | 2019-02-22 |
| Trial of Pembrolizumab in Cancer of Unknown Primary (NCT03752333) | Imperial College London | 2019-02-22 |
| Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) (NCT03824483) | Memorial Sloan Kettering Cancer Center | 2019-02-22 |
| A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis (NCT03880266) | Journey Medical Corporation | 2019-02-22 |
| Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma (NCT03782064) | Beth Israel Deaconess Medical Center | 2019-02-22 |
| Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C (NCT03471143) | Washington University School of Medicine | 2019-02-22 |
| Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers (NCT03860207) | Y-mAbs Therapeutics | 2019-02-22 |
| Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease (NCT03491215) | Novartis Pharmaceuticals | 2019-02-21 |
| Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus Prevention (NCT03852524) | Ohio State University | 2019-02-21 |
| A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier (NCT03901144) | ACO Hud Nordic AB | 2019-02-21 |
| Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain (NCT03873818) | M.D. Anderson Cancer Center | 2019-02-21 |
| Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer (NCT04192331) | Peking University Cancer Hospital & Institute | 2019-02-21 |
| Sunitinib in Sarcomas of the Central Nervous System (NCT03641326) | National Cancer Institute (NCI) | 2019-02-21 |
| Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis (NCT03837743) | Durect | 2019-02-21 |
| Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC (NCT03625323) | Immutep S.A.S. | 2019-02-21 |
| A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months (NCT03818815) | Novus Therapeutics, Inc | 2019-02-21 |
| A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer (NCT03854617) | Chinese Academy of Medical Sciences | 2019-02-20 |
| The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer (NCT04129216) | Johns Hopkins University | 2019-02-20 |
| Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological Hospital (NCT04411069) | Instituto do Cancer do Estado de São Paulo | 2019-02-20 |
| Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted (NCT03832114) | Novartis Pharmaceuticals | 2019-02-20 |
| Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS (NCT03792490) | University Medical Center Goettingen | 2019-02-20 |
| Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms (NCT03878199) | Ohio State University Comprehensive Cancer Center | 2019-02-20 |
| Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD (NCT03501979) | University of Alabama at Birmingham | 2019-02-20 |
| Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus (NCT03723551) | Debiopharm International SA | 2019-02-20 |
| An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection (NCT02972450) | ANRS, Emerging Infectious Diseases | 2019-02-20 |